//./ActionParams/@language -> $page_language ->
The Economic Times
English EditionEnglish Editionहिन्दी
| 21 October, 2020, 04:34 PM IST | E-Paper
Search
+
    ENG
    • ENG - English
    • HIN - हिन्दी
    • GUJ - ગુજરાતી
    • MAR - मराठी
    • BEN - বাংলা 
    • KAN - ಕನ್ನಡ 
    • ORI - ଓଡିଆ
    • TEL - తెలుగు
    • TAM - தமிழ்

    Natco Pharma Ltd.

    OPEN TRADING A/C
    • NSE
    • BSE
    Last Updated on 21 Oct, 2020, 03:59 PM IST
    929.90

    Today's Change

    5.50 (0.59%)

    Volume
    AVERAGE VOLUME
    5-Day
    10-Day
    30-Day

    273,460

    Open

    929.00

    Prev. Close

    924.40

    Day's Trend

    Low
    917.90
    High
    936.45
    • Bid
    • Mkt Cap (₹ Cr.)
    • P/E (x)
    • P/B (x)
    • Div_ Yield (%)
    • BETA
      BETA
      1 Month
      3-Months
      6-Months
      1 Year
      3-Years
    • Offer
    • Face Value (₹)2.00
    • EPS-TTM (Rs.)24.17
    • BV/share (₹)207.74
    • 52Wk L/H402.55/ 996.00
    • Avg. Daily Volatility %
      Avg. Daily Volatility %
      1 Month
      3-Months
      6-Months
      1 Year
      3-Years
    InsightsCandle Pattern| Events| Recos| Updates| News
    Natco Pharma Ltd.Statement Of Investor Complaints For The Quarter Ended September 2020| Announcement
    Natco Pharma Ltd.Compliance Certificate For The Quarter Ended September 30, 2020| Announcement
    Natco Pharma Ltd.Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018| Announcement
    Natco Pharma Ltd.Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)| Announcement
    Natco Pharma Ltd.Shareholder Meeting / Postal Ballot-Scrutinizers Report| Announcement
    Natco Pharma Ltd.Shareholder Meeting / Postal Ballot-Outcome of AGM| Announcement
    Natco Pharma Ltd.PCS Compliance Certificate For The Period Ended 30Th September,2020| Announcement
    Natco Pharma Ltd.Shareholding for the Period Ended September 30, 2020| Announcement
    Natco Pharma Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
    Natco Pharma Ltd.Closure of Trading Window| Announcement
    Natco Pharma Ltd.Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011| Announcement
    Natco Pharma Ltd.Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011| Announcement
    Natco Pharma Ltd.Announcement under Regulation 30 (LODR)-Newspaper Publication| Announcement
    Natco Pharma Ltd.37Th Annual General Meeting To Be Held On 15Th October, 2020| Announcement
    Natco Pharma Ltd.Book Closure For The Purpose Of 37Th Annual General Meeting To Be Held On 15Th October, 2020| Announcement
    Natco Pharma Ltd.Reg. 34 (1) Annual Report| Announcement
    Natco Pharma Ltd.Reg. 34 (1) Annual Report| Announcement
    Natco Pharma Ltd.Outcome Of The Board Meeting Held On 10Th September, 2020| Announcement
    Natco Pharma Ltd.Announcement under Regulation 30 (LODR)-Investor Presentation| Announcement
    Natco Pharma Ltd.Announcement under Regulation 30 (LODR)-Dividend Updates| Announcement

    Natco Pharma Ltd. Share Price Updates

    Natco Pharma Ltd. share price up by 0.59% from its previous close of Rs 924.40. Natco Pharma Ltd. stock last traded price is 929.90
    Natco Pharma Ltd. Share Price
    Value
    Today/Current/Last
    929.90
    Previous Day
    924.40
    What's your view on Natco Pharma for the week?
    Bearish
    Bullish
    View community Outlook >>

    Be the first one to post on Natco Pharma Ltd.

    Natco Pharma Ltd.
    Quarterly Results

    Figures in Rs. Cr
    Jun 2020 
    % Chg (Quarterly)
    % Chg (Yearly)
    Peer Range
    Trend
    Last 12 Quarters Trend
    Sales
    563.40
    23.88
    14.44
    0.00
    7585.25
    Other Operating Income
    0.00
    0.00
    0.00
    -0.72
    118.06
    Operating Profit
    171.10
    33.36
    -10.56
    -14.20
    2526.83
    Other Income
    18.70
    -16.52
    -10.95
    0.00
    153.79
    EBITDA
    189.80
    25.95
    -10.60
    -14.20
    2526.83
    Interest
    3.70
    5.71
    -43.08
    0.00
    102.00
    Depreciation
    28.00
    -8.20
    27.27
    0.00
    495.92
    Tax
    36.00
    53.19
    -12.20
    -110.66
    305.90
    Net Profit
    122.80
    30.50
    -14.25
    -1655.60
    780.58
    EPS (₹)
    6.73
    30.43
    -14.27
    -10.81
    68.30

    Natco Pharma Ltd Share Price

    Vs Peers
    Companies
    LTP
    Intraday
    1W %
    1M %
    1 QTR %
    1 YR %
    3 YR %
    5 Yr %
    Trend -
    D|M|Y
    929.90
    0.59
    3.18
    4.23
    37.76
    63.76
    -5.79
    77.96
    489.50
    1.45
    0.64
    3.39
    18.19
    63.25
    -19.56
    -51.92
    491.35
    -0.51
    -1.87
    -4.55
    14.36
    16.27
    -14.44
    0.00
    333.85
    -0.89
    2.58
    17.15
    156.91
    427.91
    206.28
    0.00
    1603.35
    1.81
    2.46
    0.80
    12.42
    58.38
    34.11
    2.10
    995.40
    1.41
    3.93
    8.14
    0.01
    82.98
    98.60
    38.60
    706.05
    1.68
    -0.57
    -8.36
    -2.47
    40.35
    10.70
    69.52
    386.35
    -1.43
    0.53
    7.16
    46.76
    280.64
    168.95
    157.65
    552.20
    -0.49
    -0.03
    -1.23
    30.28
    66.20
    118.65
    194.27
    1022.00
    -1.73
    -1.83
    -5.29
    42.89
    178.82
    274.77
    240.21
    984.50
    0.80
    1.41
    -6.06
    9.65
    22.37
    119.12
    276.65
    Top Loser for the period amongst the peers
    Top Gainer for the period amongst the peers

    Natco Pharma Ltd Risk Return Comparison

    with peersNew

    Natco Pharma Ltd
    Financial Comparison

    with peers
    Management Efficiency
    Natco Pharma Ltd 
    peer Average
    Peer Range
    Trend
    Return on Equity (%)
    12.21
    6.13
    -97.73
    37.52
    Return on Assets (%)
    10.30
    4.29
    -51.80
    37.98
    Return on capital Employed (%)
    9.11
    7.15
    -86.49
    32.77
    Fixed Assets Turnover (x)
    0.48
    0.43
    -36.70
    3.05
    Profitability and Growth
    Gross Profit Margin (%)
    25.21
    -3.48
    -831.69
    43.32
    Operating Profit Margin(%)
    30.42
    3.00
    -802.77
    46.18
    Net Profit margin (%)
    24.06
    -9.08
    -653.62
    38.01
    Financial Strength
    Liquidity
    Quick Ratio (x)
    3.73
    2.00
    0.08
    37.52
    Current Ratio (x)
    4.87
    2.77
    0.21
    37.52
    Cash ratio (x)
    0.14
    0.24
    0.00
    2.43
    Solvency
    Debt Equity Ratio (x)
    NaN
    0.24
    0.00
    3.08
    Coverage Ratios
    Cash flows to long term debt (x)
    0.57
    2.78
    0.00
    24.88
    Better performer than its peers on this ratioAverage performer than its peers on this ratioUnderperformer than its peers on this ratio

    Natco Pharma Ltd Share Holding as on 30-09-2020

    CategoryNo. of sharesPercentage
    Promoters89,103,24548.91
    ForeignInstitutions35,185,41719.31
    NBanksMutualFunds16,867,0489.26
    Others5,853,4603.21
    GeneralPublic27,060,54414.85
    FinancialInstitutions8,116,6214.46

    MF Ownership Of Natco Pharma Ltd. Shares

    Fund Name
    Category
    No. of shares
    % Change in Shares (MOM basis)
    % of AUM
    Amount Invested (in ₹ Cr)
    Mirae Asset Emerging Bluechip Direct-G
    Portfolio as on 30-09-2020
    Equity: Large & MidCap
    2520614
    13.01%
    2.09%
    239.43
    Sundaram Mid Cap Direct-G
    Portfolio as on 30-09-2020
    Equity: Mid Cap
    1675613
    9.83%
    2.98%
    159.17
    Equity: Large & MidCap
    1144127
    0.00%
    2.48%
    108.68
    SBI Magnum Midcap Direct-G
    Portfolio as on 30-09-2020
    Equity: Mid Cap
    1095130
    0.00%
    2.84%
    104.03
    ICICI Pru Multicap Direct-G
    Portfolio as on 30-09-2020
    Equity: Multi Cap
    1005108
    0.00%
    1.82%
    95.48

    Liquid, Ultra Short Term funds and FMPs are not taken into account.

    More Schemes »

    About Natco Pharma Ltd.

    Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 16899.60 Crore) operating in Pharmaceuticals sector.

    Natco Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 1931.70 Crore to Sales Value (97.25 % of Total Sales), Export Incentives which contributed Rs 29.70 Crore to Sales Value (1.49 % of Total Sales), Job Work which contributed Rs 15.00 Crore to Sales Value (0.75 % of Total Sales), Sale of services which contributed Rs 6.80 Crore to Sales Value (0.34 % of Total Sales) and Scrap which contributed Rs 3.10 Crore to Sales Value (0.15 % of Total Sales)for the year ending 31-Mar-2019.

    For the quarter ended 30-06-2020, the company has reported a Consolidated sales of Rs 563.40 Crore, up 23.88 % from last quarter Sales of Rs 454.80 Crore and up 14.44 % from last year same quarter Sales of Rs 492.30 Crore Company has reported net profit after tax of Rs 122.10 Crore in latest quarter.

    The company’s top management includes Dr.D Linga Rao Donthineni, Mr.T V Rao, Mr.Sridhar Sankararaman, Mr.Rajeev Nannapaneni, Mr.P S R K Prasad, Mr.G S Murthy, Mr.D G Prasad, Dr.M U R Naidu, Dr.Leela Digumarti, Mr.V C Nannapaneni. Company has Walker, Chandiok & Co.LLP as its auditors. As on 30-09-2020, the company has a total of 182,186,335 shares outstanding.

    Close X
    WatchlistPortfolio

    Current Price>: 2389.88

    Set Alert

    Loading
    Please wait...

    Date Sources:Live BSE and NSE Quotes Service: TickerPlant | Corporate Data, F&O Data & Historical price volume data: Dion Global Solutions Ltd.
    BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. NSE Quotes and Nifty are also real time and licenced from National Stock Exchange. All times stamps are reflecting IST (Indian Standard Time).
    By using this site, you agree to the Terms of Service and Privacy Policy.

    The Economic Times

    Loadingdata
    More on:
    Prices| Financials | Company Info | Reports | News | Competitors